Skip to main content

Advertisement

Log in

Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Ectopic ACTH syndrome (EAS) is rare. We established a national cohort to increase awareness and address unmet needs.

Methods

The Finnish national EAS cohort includes 60 patients diagnosed in 1997–2016. We assessed clinical features, diagnostic work-ups, treatments, incidence, and outcomes of subgroups occult tumor (OT), well-differentiated neuroendocrine tumor G1/G2 (NETG1/G2) and NET G3/neuroendocrine carcinoma (NETG3/NEC).

Results

The distribution of OT, NETG1/G2, and NETG3/NEC was 10 (17%), 20 (33%), and 30 (50%), respectively; and median follow-up 22 months (0–249). Annual incidence (0.20–0.93 per million inhabitants) and tumor subgroups (OT vs. NEC) varied across the country. The longest diagnostic delay from EAS onset to radiological tumor identification was 48 months. In NET/NEC, 6/50 (12%) were diagnosed 1–24 years before EAS onset. Osteoporotic fractures (32%) and severe infections (55%) were common. The CRH stimulation test accurately diagnosed EAS in 25/31 (81%). Metyrapone (≤6 g daily, prescribed in 88%) was well tolerated. In NETG1/G2, 13/20 (65%) underwent curative resection of the primary tumor; four experienced recurrence within 2–12 years. In OT, 70% underwent bilateral adrenalectomy. Five-year overall survival in OT, NETG1/G2, and NETG3/NEC was 90%, 55%, and 0%, respectively (P < 0.001). Morning cortisol, hypokalemia, infections, metastatic disease, and acute onset were negative, whereas resection of the primary tumor and bilateral adrenalectomy were positive predictors of survival.

Conclusions

NET/NEC may precede EAS onset by several years. In NETG1/G2, recurrences may occur > 10 years after successful primary surgery. Tumor subgroup (OT, NETG1/G2, NEC) was an independent predictor of survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and material

(Data transparency) yes.

Code availability

(Software application or custom code) not applicable (word document and figure files).

References

  1. I. Ilias, D.J. Torpy, K. Pacak, N. Mullen, R.A. Wesley, L.K. Nieman, Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 90, 4955–4962 (2005)

    Article  CAS  Google Scholar 

  2. J. Young, M. Haissaguerre, O. Viera-Pinto, O. Chabre, E. Baudin, A. Tabarin, MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur. J. Endocrinol. 182, R29–R58 (2020)

    Article  CAS  Google Scholar 

  3. K.I. Alexandraki, A.B. Grossman, The ectopic ACTH syndrome. Rev. Endocr. Metab. Disord. 11, 117–126 (2010)

    Article  Google Scholar 

  4. A. Osswald, T. Deutschbein, C.M. Berr, E. Plomer, A. Mickisch, K. Ritzel, J. Schopohl, F. Beuschlein, M. Fassnacht, S. Hahner, M. Reincke, Surviving ectopic Cushing’s syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing’s disease during long-term follow-up. Eur. J. Endocrinol. 179, 109–116 (2018)

    Article  CAS  Google Scholar 

  5. M.V. Davi’, E. Cosaro, S. Piacentini, G. Reimondo, N. Albiger, G. Arnaldi, A. Faggiano, G. Mantovani, N. Fazio, A. Piovesan, E. Arvat, F. Grimaldi, L. Canu, M. Mannelli, A.G. Ambrogio, F. Pecori Giraldi, C. Martini, A. Lania, M. Albertelli, D. Ferone, M.C. Zatelli, D. Campana, A. Colao, C. Scaroni, M. Terzolo, L. De Marinis, S. Cingarlini, R. Micciolo, G. Francia, Prognostic factors in ectopic Cushing’s syndrome due to neuroendocrine tumors: a multicenter study. Eur. J. Endocrinol. 176, 453–461 (2017)

    Article  Google Scholar 

  6. A.R. Hayes, A.B. Grossman, The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging. Endocrinol. Metab. Clin. North Am. 47, 409–425 (2018)

    Article  Google Scholar 

  7. G. Rindi, D.S. Klimstra, B. Abedi-Ardekani, S.L. Asa, F.T. Bosman, E. Brambilla, K.J. Busam, R.R. de Krijger, M. Dietel, A.K. El-Naggar, L. Fernandez-Cuesta, G. Klöppel, W.G. McCluggage, H. Moch, H. Ohgaki, E.A. Rakha, N.S. Reed, B.A. Rous, H. Sasano, A. Scarpa, J.Y. Scoazec, W.D. Travis, G. Tallini, J. Trouillas, J.H. van Krieken, I.A. Cree, A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod. Pathol. 31, 1770–1786 (2018)

    Article  Google Scholar 

  8. C. Schalin-Jäntti, A. Ahonen, M. Seppänen, 18F-DOPA PET/CT but not 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome. Clin. Nucl. Med. 37, 904–905 (2012)

    Article  Google Scholar 

  9. C. Schalin-Jäntti, S.L. Asa, J. Arola, T. Sane, Recurrent acute-onset Cushing’s syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH. Endocr. Pathol. 24, 25–29 (2013)

    Article  Google Scholar 

  10. J.E. Paleń-Tytko, E.M. Przybylik-Mazurek, E.J. Rzepka, D.M. Pach, A.S. Sowa-Staszczak, A. Gilis-Januszewska, A.B. Hubalewska-Dydejczyk, Ectopic ACTH syndrome of different origin-Diagnostic approach and clinical outcome. Experience of one Clinical Centre. PLoS One 15, e0242679 (2020)

    Article  Google Scholar 

  11. I. Lase, I. Strele, M. Grönberg, G. Kozlovacki, S. Welin, E.T. Janson, Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing’s syndrome. Hormones 19, 351–360 (2020)

    Article  Google Scholar 

  12. : Facts on Finland and Finnish Health Care system. In: Martikainen, J., Pajunen, R., Saastamoinen, L., Kalliokoski, A., Voipio, T. (eds.) Suomen lääketilasto Finnish Statistics on Medicines 2010, pp. 37-39. Finnish Medicines Agency Fimea and the Social Insurance Institution (Kela), Helsinki (2011)

  13. C. Steffensen, A.M. Bak, K.Z. Rubeck, J.O. Jørgensen, Epidemiology of Cushing’s syndrome. Neuroendocrinology 92(Suppl 1), S1–S5 (2010)

    Article  Google Scholar 

  14. A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386, 913–927 (2015)

    Article  CAS  Google Scholar 

  15. G. Rubinstein, A. Osswald, E. Hoster, M. Losa, A. Elenkova, S. Zacharieva, M.C. Machado, F.A. Hanzu, S. Zopp, K. Ritzel, A. Riester, L.T. Braun, I. Kreitschmann-Andermahr, H.L. Storr, P. Bansal, M.J. Barahona, E. Cosaro, S.C. Dogansen, P.C. Johnston, R. Santos de Oliveira, C. Raftopoulos, C. Scaroni, E. Valassi, S.J.A. van der Werff, J. Schopohl, F. Beuschlein, M: Reincke, Time to diagnosis in Cushing’s syndrome: a meta-analysis based on 5367 patients. J. Clin. Endocrinol. Metab. 105, dgz136 (2020). https://doi.org/10.1210/clinem/dgz136

    Article  PubMed  Google Scholar 

  16. J.P. Aniszewski, W.F. Young Jr, G.B. Thompson, C.S. Grant, J.A. van Heerden, Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J. Surg. 25, 934–940 (2001)

    Article  CAS  Google Scholar 

  17. F. Beuschlein, G.D. Hammer, Ectopic pro-opiomelanocortin syndrome. Endocrinol. Metab. Clin. North Am. 31, 191–234 (2002)

    Article  CAS  Google Scholar 

  18. G. Klöppel, S. La Rosa, Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms. Virchows Arch. 472, 341–349 (2018)

    Article  Google Scholar 

  19. A.M. Isidori, A. Lenzi, Ectopic ACTH syndrome. Arq. Bras. Endocrinol. Metabol. 51, 1217–1225 (2007)

    Article  Google Scholar 

  20. A.M. Isidori, E. Sbardella, M.C. Zatelli, M. Boschetti, G. Vitale, A. Colao, R. Pivonello; ABC Study Group, Conventional and nuclear medicine imaging in ectopic Cushing’s syndrome: a systematic review. J. Clin. Endocrinol. Metab. 100, 3231–3244 (2015)

    Article  CAS  Google Scholar 

  21. A.M. Isidori, G.A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R.H. Reznek, P.J. Jenkins, J.P. Monson, A.B. Grossman, G.M. Besser, The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J. Clin. Endocrinol. Metab. 91, 371–377 (2006)

    Article  CAS  Google Scholar 

  22. S. Sathyakumar, T.V. Paul, H.S. Asha, B.R. Gnanamuthu, M.J. Paul, D.T. Abraham, S. Rajaratnam, N. Thomas, Ectopic Cushing syndrome: a 10-year experience from a tertiary care center in Southern India. Endocr. Pract. 23, 907–914 (2017)

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the Helsinki University Hospital Research Funds (TYH2018223, TYH2019254) and Finska Läkaresällskapet (not numbered) (to C.S.-J.).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed sufficiently (data collection, approving final manuscript as the minimum) to be listed as authors.

Corresponding author

Correspondence to Camilla Schalin-Jäntti.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest that could be perceived as prejudicing the impartiality of the research reported.

Ethical approval

This study was conducted in accordance with the Declaration of Helsinki. Authorization to perform this study without individual consent was granted by the Ethical Committee of the Helsinki University Central Hospital (HUS 2024/2016) and the Review Boards of the individual hospitals.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toivanen, S., Leijon, H., Arola, A. et al. Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort. Endocrine 74, 387–395 (2021). https://doi.org/10.1007/s12020-021-02768-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02768-0

Keywords

Navigation